PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis

被引:458
作者
Jiang, Bing-Hua [1 ,2 ,3 ]
Liu, Ling-Zhi [1 ,2 ]
机构
[1] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA
[2] W Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA
[3] Nanjing Med Univ, Dept Pathol, Ctr Canc, Nanjing 210029, Jiangsu, Peoples R China
来源
ADVANCES IN CANCER RESEARCH, VOL 102 | 2009年 / 102卷
关键词
ENDOTHELIAL-GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; PHASE-II TRIAL; NF-KAPPA-B; HYPOXIA-INDUCIBLE FACTOR; ADVANCED SOLID TUMORS; RENAL-CELL CARCINOMA; RECURRENT MALIGNANT GLIOMA; SMOOTH-MUSCLE-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET;
D O I
10.1016/S0065-230X(09)02002-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Phosphatidylinositol 3-kinase (PI3K) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) signaling pathway play an important role in multiple cellular functions such as cell metabolism, proliferation, cell-cycle progression, and survival. PI3K is activated by growth factors and angiogenesis inducers such is vascular endothelial growth factor (VEGF) and angiopoietins. The amplification and Mutations of PI3K and the loss of the tumor suppressor PTEN are common in various kinds of human solid tumors. The genetic alterations of upstream and downstream of PI3K signaling molecules such as receptor tyrosine kinases and AKT, respectively, are also frequently altered in human cancer. PI3K signaling regulates tumor growth and angiogenesis by activating AKT and other targets, and by inducing HIF-1 and VEGF expression. Angiogenesis is required for tumor growth and metastasis. In this review, we highlight the recent studies on the roles and mechanisms of PI3K and PTEN in regulating tumorigenesis and angiogenesis, and the roles of the downstream targets of PI3K for transmitting the signals. We also discuss the crosstalk of these signaling molecules and Cellular events during tumor growth, metastasis, and tumor angiogenesis. Finally, we Summarize the potential applications of PI3K, AKT, and mTOR inhibitors and their Outcome in clinical trials for cancer treatment. (C) 2009 Elsevier Inc.
引用
收藏
页码:19 / 65
页数:47
相关论文
共 278 条
[111]   Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway [J].
Kim, I ;
Kim, HG ;
So, JN ;
Kim, JH ;
Kwak, HJ ;
Koh, GY .
CIRCULATION RESEARCH, 2000, 86 (01) :24-29
[112]   Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes [J].
Kim, JH ;
Kim, B ;
Cai, L ;
Choi, HJ ;
Ohgi, KA ;
Tran, C ;
Chen, C ;
Chung, CH ;
Huber, O ;
Rose, DW ;
Sawyers, CL ;
Rosenfeld, MG ;
Baek, SH .
NATURE, 2005, 434 (7035) :921-926
[113]   Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production [J].
Kimura, T ;
Suzuki, A ;
Fujita, Y ;
Yomogida, K ;
Lomeli, H ;
Asada, N ;
Ikeuchi, M ;
Nagy, A ;
Mak, TW ;
Nakano, T .
DEVELOPMENT, 2003, 130 (08) :1691-1700
[114]   A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial [J].
Knowling, M ;
Blackstein, M ;
Tozer, R ;
Bramwell, V ;
Dancey, J ;
Dore, N ;
Matthews, S ;
Eisenhauer, E .
INVESTIGATIONAL NEW DRUGS, 2006, 24 (05) :435-439
[115]   RETRACTED: Tumorigenesis facilitated by Pten deficiency in the skin:: Evidence of p53-Pten complex formation on the initiation phase (Retracted Article. See vol 96, pg 377, 2005) [J].
Komazawa, N ;
Suzuki, A ;
Sano, S ;
Horie, K ;
Matsuura, N ;
Mak, TW ;
Nakano, T ;
Takeda, J ;
Kondoh, G .
CANCER SCIENCE, 2004, 95 (08) :639-643
[116]   ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms [J].
Kong, Dexin ;
Yamori, Takao .
CANCER SCIENCE, 2007, 98 (10) :1638-1642
[117]   Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma [J].
Kuhn, John G. ;
Chang, Susan M. ;
Wen, Patrick Y. ;
Cloughesy, Timothy F. ;
Greenberg, Harry ;
Schiff, David ;
Conrad, Charles ;
Fink, Karen L. ;
Robins, H. Ian ;
Mehta, Minesh ;
DeAngelis, Lisa ;
Raizer, Jeffrey ;
Hess, Kenneth ;
Lamborn, Kathleen R. ;
Dancey, Janet ;
Praclos, Michael D. .
CLINICAL CANCER RESEARCH, 2007, 13 (24) :7401-7406
[118]   The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation [J].
Laramee, Melanie ;
Chabot, Catherine ;
Cloutier, Monikca ;
Stenne, Raphaelle ;
Holgado-Madruga, Marina ;
Wong, Albert J. ;
Royal, Isabelle .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (11) :7758-7769
[119]   Epithelial-mesenchymal transition in development and cancer:: role of phosphatidylinositol 3′ kinase/AKT pathways [J].
Larue, L ;
Bellacosa, A .
ONCOGENE, 2005, 24 (50) :7443-7454
[120]   Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1α-VEGF axis [J].
Lee, Kyung Sun ;
Kim, So Ri ;
Park, Seoung Ju ;
Min, Kyung Hoon ;
Lee, Ka Young ;
Choe, Yeong Hun ;
Park, Seung Yong ;
Chai, Ok Hee ;
Zhang, Xin ;
Song, Chang Ho ;
Lee, Yong Chul .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (08) :787-797